Latest news
PD-L1–positive metastatic TNBC: SG plus pembrolizumab outperforms chemo-immunotherapy in PFS and tolerability - Vera HealthVera Health · Sun, 02 Aug 2026 10:13:10 GMTCervical cancer after PD-(L)1: TIM-3/PD-1 bispecific shows early activity with low grade 3-4 toxicity - Vera HealthVera Health · Sat, 01 Aug 2026 07:17:11 GMTPD-L1–high metastatic TNBC: Pembrolizumab plus chemotherapy performs in practice - Vera HealthVera Health · Sat, 01 Aug 2026 04:39:46 GMTParkinson’s disease: gut virome shifts are detectable in prodromal and confirmed cases - Vera HealthVera Health · Fri, 31 Jul 2026 12:03:17 GMTPD-L1–high NSCLC: adding tiragolumab to atezolizumab fails to improve survival - Vera HealthVera Health · Mon, 27 Jul 2026 16:55:37 GMT